Serum soluble urokinase plasminogen activator receptor and early stage of diabetic kidney disease in patients with type 2 diabetes

被引：0
|
作者：
Wang, Tao [1 ]
机构：
[1] Nanjing Med Univ, Affiliated Hosp 1, Dept Endocrinol & Metab, Nanjing, Jiangsu, Peoples R China
来源：
DIABETES-METABOLISM RESEARCH AND REVIEWS | 2018年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
961969
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Serum soluble urokinase plasminogen activator receptor as a potential biomarker of renal impairment severity in diabetic nephropathy
    Lupusoru, Gabriela
    Ailincai, Ioana
    Sorohan, Bogdan Marian
    Andronesi, Andreea
    Achim, Camelia
    Micu, Georgia
    Caragheorgheopol, Andra
    Manda, Dana
    Lupusoru, Mircea
    Ismail, Gener
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2021, 182
  • [42] Soluble urokinase Plasminogen Activator Receptor (suPAR) serum levels are elevated in patients with neuroendocrine neoplasia
    Burcin, Oe
    Mohr, R.
    Jann, H.
    Geisler, L.
    Tacke, F.
    Wiedenmann, B.
    Roderburg, C.
    JOURNAL OF NEUROENDOCRINOLOGY, 2021, 33 : 96 - 96
  • [43] Serum soluble urokinase-type plasminogen activator receptor (suPAR) levels in male patients with acute exacerbation of schizophrenia
    Genc, A.
    Kalelioglu, T.
    Karamustafalioglu, N.
    Tasdemir, A.
    Genc, E. Sena
    Akkus, M.
    Emul, M. H.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2015, 25 : S232 - S233
  • [44] Serum soluble urokinase plasminogen activator receptor (suPAR) in early pregnancy prior to clinical onset of preeclampsia
    Odden, Nancy
    Henriksen, Tore
    Morkrid, Lars
    ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2012, 91 (10) : 1226 - 1232
  • [45] Renin angiotensin system blockade reduces urinary levels of soluble urokinase plasminogen activator receptor (suPAR) in patients with type 2 diabetes
    Persson, Frederik
    Theilade, Simone
    Eugen-Olsen, Jesper
    Rossing, Peter
    Parving, Hans-Henrik
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2016, 30 (08) : 1440 - 1442
  • [46] Serum soluble urokinase-type plasminogen activator receptor (suPAR) is a useful marker of prostate cancer
    不详
    EUROPEAN UROLOGY SUPPLEMENTS, 2006, 5 (02) : 275 - 275
  • [47] Elevated Plasma Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR) in Sickle Cell Disease - a Marker of Chronic Kidney Disease
    Afangbedji, Nowah Kokou Apeadoufia
    Taylor, James G.
    Nekhai, Sergei
    Jerebtsova, Marina
    BLOOD, 2021, 138
  • [48] Clinical significance of serum soluble urokinase-type plasminogen activator receptor in children with Alport syndrome
    Zhang, Y.
    Ding, J.
    Wang, F.
    Ding, F.
    Xiao, H.
    Yao, Y.
    PEDIATRIC NEPHROLOGY, 2016, 31 (10) : 1804 - 1805
  • [49] THE IMPORTANCE OF SOLUBLE UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR IN PATIENTS WITH ACUTE BRUCELLOSIS
    Demir, Nazlim Aktug
    Dagi, Hatice Turk
    Findik, Duygu
    Sumer, Sua
    Ural, Onur
    Kolgelier, Servet
    NOBEL MEDICUS, 2015, 11 (01): : 87 - 91
  • [50] Soluble urokinase plasminogen activator receptor in patients with abdominal aortic aneurysm
    Lindqvist, Markus
    Wallinder, Jonas
    Henriksson, Anders E.
    THROMBOSIS RESEARCH, 2012, 130 (03) : 511 - 513
12345